Peplib

PepLib is discovering new peptide drugs for various applications. Using their peptide discovery platform, Peptide Information Compression Technology (PICT), which contains information on nearly half a billion peptides, PepLib is conducting high-throughput screening assays to identify active peptides of value. In addition, PepLib has complimentary discovery pipelines for animal toxin peptides and their virtual peptide library. PepLib’s current therapeutic focus is oncology and cardiometabolic diseases. The oncology program includes development of both peptide drug conjugates and peptide radionuclide conjugates.

Jobs: